Single voxel proton magnetic resonance spectroscopy ('H MRS) was used to study the metabolites N-acetyl-aspartate (NAA), choline (CHO), and myo-inositol (ml) in order to test a neurodegenerative hypothesis in schizophrenia (decrease of NAA, increase of CHO, and increase of ml) and a cerebral asymmetry of these metabolites. 1H MRS was performed in 17 schizophre-nia patients and 14 healthy subjects in three cerebral areas highly involved in the pathophysiology of schizo-phrenia (the prefrontal cortex, the thalamus, and the hippocampus). The ratio amplitudes between metabo-lites and creatine plus phosphocreatine (Cr) were determined. No difference in the metabolites existed between patients and healthy subjects. However, rela-tionships we...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
Managing affective, negative, and cognitive symptoms remains the most difficult therapeutic problem ...
Managing affective, negative, and cognitive symptoms remains the most difficult therapeutic problem ...
Objectives: The aim of this study was to investigate medial prefrontal cortex neurochemical metaboli...
Objectives: The aim of this study was to investigate medial prefrontal cortex neurochemical metaboli...
Objective: Reduced N-acetylaspartate levels in regions of the frontal cortex, including the anterior...
Objective: Reduced N-acetylaspartate levels in regions of the frontal cortex, including the anterior...
In adult schizophrenia, magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) h...
N-acetyl-aspartate (NAA) is a readily measured marker of neuronal metabolism. Previous analyses in s...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
Schizophrenia is a brain disease that affects about one in every 100 Canadians. Approximately 40% of...
The aim of this study was to compare schizoaffective disorder, bipolar disorder and schizophrenia ba...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
Background/aim: The aim of this study was to compare metabolite levels of the dorsolateral prefronta...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
Managing affective, negative, and cognitive symptoms remains the most difficult therapeutic problem ...
Managing affective, negative, and cognitive symptoms remains the most difficult therapeutic problem ...
Objectives: The aim of this study was to investigate medial prefrontal cortex neurochemical metaboli...
Objectives: The aim of this study was to investigate medial prefrontal cortex neurochemical metaboli...
Objective: Reduced N-acetylaspartate levels in regions of the frontal cortex, including the anterior...
Objective: Reduced N-acetylaspartate levels in regions of the frontal cortex, including the anterior...
In adult schizophrenia, magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) h...
N-acetyl-aspartate (NAA) is a readily measured marker of neuronal metabolism. Previous analyses in s...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
Schizophrenia is a brain disease that affects about one in every 100 Canadians. Approximately 40% of...
The aim of this study was to compare schizoaffective disorder, bipolar disorder and schizophrenia ba...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
Background/aim: The aim of this study was to compare metabolite levels of the dorsolateral prefronta...
By reviewing the existing H-1-magnetic resonance spectroscopy literature in schizophrenia, the relat...
Managing affective, negative, and cognitive symptoms remains the most difficult therapeutic problem ...
Managing affective, negative, and cognitive symptoms remains the most difficult therapeutic problem ...